AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $8,865,000 | -48.6% | 300,000 | +7.1% | 0.88% | -24.4% |
| Q3 2018 | $17,234,000 | +50.1% | 280,000 | +64.7% | 1.16% | -8.7% |
| Q2 2018 | $11,484,000 | +76.4% | 170,000 | +41.7% | 1.28% | +38.8% |
| Q1 2018 | $6,510,000 | +283.4% | 120,000 | +166.7% | 0.92% | +230.6% |
| Q3 2016 | $1,698,000 | -35.9% | 45,000 | -70.0% | 0.28% | -69.9% |
| Q2 2015 | $2,648,000 | – | 150,000 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |